In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of ...
Novo Nordisk launches Ozempic in India, outlining prices, doses, and its bid to capture rising diabetes and weight-loss ...
A major moment in India’s fight against type-2 diabetes arrived this week with the launch of Ozempic, the globally popular semaglutide drug known for its strong effects on blood sugar control and ...
The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...
Looking to expand its footprint in the booming glucagon-like peptide (GLP-1) market, Danish drugmaker Novo Nordisk has ...
Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...
A Division Bench of Delhi High Court on Friday declined to stay a Single Judge’s order that had allowed Dr Reddy’s ...
Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.
A notable finding is that audiences are split on whether they see more pharma ads in 2025 compared to 2024. Nearly half of ...
Stockhead on MSN
Biocurious: AI becomes the hidden helping hand in clinical trial design and analysis
Drug developers increasingly are harnessing AI to optimise clinical trial patient selection and to interpret results to ...
Novo Nordisk has the potential to maintain more consistent revenue growth throughout next year. There is an indication that the company's pipeline candidates will see strong progress in 2026. Novo ...
In this week's episode of The Envelope podcast, Tonatiuh discusses 'Kiss of the Spider Woman' and Kate Hudson talks 'Song ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results